Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Atyr Pharma Inc. Cm

TRADE

NASDAQ: LIFEHealthcare / Biotechnology / USA
0.65+0.04+6.56%Vol 437 5071Y Perf -75.89%
Aug 17th, 2018 16:00
BID0.62 ASK0.65
Open0.65 Previous Close0.61
Pre-Market- After-Trading0.67
 - -%  0.02 3.08%
Target Price
3.00 
Analyst Rating
Hold 3.00
Potencial %
361.54 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/40 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/95 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/98 
Income Ranking
 —    -
Market Cap (mil)19 
Earnings Rating
Price Range Ratio 52wk %
0.85 
Earnings Date

Today's Price Range

0.610.67

 

52wk Range

0.606.50

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-31.46%
3 Months
-37.76%
6 Months
-80.63%
1 Year
-75.89%
3 Years
-96.21%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
LIFE0.650.04006.56
AAPL217.584.26002.00
GOOG1 200.96-5.5300-0.46
MSFT107.58-0.0600-0.06
XOM78.260.26000.33
WFC58.860.20000.34
JNJ134.471.99001.50
FB173.80-0.9000-0.52
GE12.300.00000.00
JPM114.770.00000.00
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 6.70
Current Ratio 6.90
Long Term Debt to Total Capital 0.19
Total Debt to Equity 0.37
Interest Coverage -
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.38
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.70
Cash Flow Per Share -1.43
Price to Tangible Book0.38
Book Value per Share1.83
Enterprise Value (in ths.)-33 624
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-242.73
ROE last 12 Months -86.44
Return on Assets (5Y Avg) -55.61
ROA last 12 Months -63.06
Return on Capital (5Y Avg) -
ROC last 12 Months -67.49
Return on invested Capital Q -13.46
Return on invested Capital Y-61.68
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.34-0.35-2.94
Q01 2018-0.35-0.36-2.86
Q04 2017-0.43-0.399.30
Q03 2017-0.51-0.4315.69
Q02 2017-0.57-0.5110.53
Q01 2017-0.55-0.56-1.82
Q04 2016-0.61-0.5313.11
Q03 2016-0.67-0.5813.43
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.3236.00Positive
9/2018 QR-0.2648.00Positive
12/2018 FY-1.1833.71Positive
12/2019 FY-1.1458.84Positive
Next Report Date14th Aug 2018
Estimated EPS Next Report-0.34
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume437 507
Shares Outstanding (in ths.)29 860
Trades Count644
Dollar Volume264 132
Avg. Volume454 907
Avg. Weekly Volume969 481
Avg. Monthly Volume655 445
Avg. Quarterly Volume951 886

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

71%29%

Bearish Bullish

55%45%

Bearish Bullish

81%19%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x